Literature DB >> 9813625

Crystallization and stone formation inside the nephron.

D J Kok1.   

Abstract

A model is presented visualizing the events leading to calcium-salt, crystal- and stone-formation inside the nephron. For each nephron segment, handling of urine components relevant to stone formation is considered and urine composition determined. This information was applied to nucleation experiments simulating passage of urine through a nephron. The model and in vitro experiments suggest that within normal transit times for the respective nephron segments, particles of a hydroxyapatite-like material first form near the bend in the Loop of Henle of juxtamedullary nephrons. From there on, calcium oxalate particles start to appear: first dihydrate, then monohydrate. In the collecting duct system, particle size increases primarily due to crystal agglomeration. Several conclusions with clinical and experimental relevance can be drawn. An increase in urinary volume does not decrease the chance of crystal formation in the Loop of Henle, but does decrease passage time through the collecting ducts, and thus, the time allowed for large particle formation. A calcium load does not increase the risk for nucleation up to the distal tubule, but does increase the risk of large particle formation in the collecting ducts. An oxalate load increases the chance for nucleation throughout the nephron. For experiments simulating crystallization processes occurring inside the nephron, diluted urines should be used. They should be diluted 16 to 50 times for testing nucleation, 2 to 30 times for testing crystal growth, and 2 to 20 times for testing crystal agglomeration. Undiluted urines may be used to mimic conditions in the pelvis and the bladder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9813625

Source DB:  PubMed          Journal:  Scanning Microsc        ISSN: 0891-7035


  10 in total

1.  Impact of hypoxia and hypercapnia on calcium oxalate toxicity in renal epithelial and interstitial cells.

Authors:  Yanwei Cao; Sreedhar Sagi; Axel Häcker; Annette Steidler; Peter Alken; Thomas Knoll
Journal:  Urol Res       Date:  2006-04-22

Review 2.  The tubular epithelium in the initiation and course of intratubular nephrocalcinosis.

Authors:  Benjamin A Vervaet; Anja Verhulst; Marc E De Broe; Patrick C D'Haese
Journal:  Urol Res       Date:  2010-08-02

Review 3.  The role of calcium phosphate in the development of Randall's plaques.

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2013-08-21       Impact factor: 3.436

Review 4.  Intratubular crystallization events.

Authors:  D J Kok
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 5.  A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-19

6.  Simulating calcium salt precipitation in the nephron using chemical speciation.

Authors:  Allen L Rodgers; Shameez Allie-Hamdulay; Graham Jackson; Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-20

7.  Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.

Authors:  Hans-Göran Tiselius; Bengt Lindbäck; Anne-Marie Fornander; Mari-Anne Nilsson
Journal:  Urol Res       Date:  2009-05-15

8.  The influence of oxalate on renal epithelial and interstitial cells.

Authors:  Thomas Knoll; Annette Steidler; Lutz Trojan; Sreedhar Sagi; Axel Schaaf; Benito Yard; Maurice Stephan Michel; Peter Alken
Journal:  Urol Res       Date:  2004-06-10

9.  Vitamin D receptor gene polymorphisms and susceptibility to urolithiasis: a meta-regression and meta-analysis.

Authors:  Danyal Imani; Bahman Razi; Arezou Khosrojerdi; Kaivan Lorian; Morteza Motallebnezhad; Ramazan Rezaei; Saeed Aslani
Journal:  BMC Nephrol       Date:  2020-07-10       Impact factor: 2.388

Review 10.  Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.

Authors:  R Geraghty; K Wood; J A Sayer
Journal:  Urolithiasis       Date:  2020-07-27       Impact factor: 3.436

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.